These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 7150484

  • 1. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
    Overgaard J, Overgaard M, Nielsen OS, Pedersen AK, Timothy AR.
    Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
    [Abstract] [Full Text] [Related]

  • 2. Interactions of radiation, cyclophosphamide and nimorazole in a C3H mammary carcinoma in vivo.
    Zachariae C, Overgaard J.
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1445-8. PubMed ID: 3759571
    [Abstract] [Full Text] [Related]

  • 3. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J.
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [Abstract] [Full Text] [Related]

  • 4. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K, Takahashi M, Nishidai T, Dodo Y, Shibamoto Y, Hiraoka M, Yukawa Y, Abe M.
    Radiat Med; 1984 Jan; 2(1):71-5. PubMed ID: 6242712
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y, Murayama C, Maezawa H, Mori T.
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [Abstract] [Full Text] [Related]

  • 7. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW.
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [Abstract] [Full Text] [Related]

  • 8. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R, Tsujitani M, Horsman MR.
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [Abstract] [Full Text] [Related]

  • 9. The radiosensitizing effects of misonidazole (MISO) in combination with diethyl maleate (DEM) in mouse mammary tumors.
    Ono K, Komuro C, Nishidai T, Shibamoto Y, Dodo Y, Takahashi M, Abe M, Shrieve DC.
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1843-7. PubMed ID: 3759535
    [Abstract] [Full Text] [Related]

  • 10. Reevaluation of the radiosensitizing effects of sanazole and nimorazole in vitro and in vivo.
    Sugie C, Shibamoto Y, Ito M, Ogino H, Suzuki H, Uto Y, Nagasawa H, Hori H.
    J Radiat Res; 2005 Dec; 46(4):453-9. PubMed ID: 16394636
    [Abstract] [Full Text] [Related]

  • 11. A phase I clinical study of Nimorazole as a hypoxic radiosensitizer.
    Timothy AR, Overgaard J, Overgaard M.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1765-8. PubMed ID: 6480460
    [Abstract] [Full Text] [Related]

  • 12. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ, de Ronde J, Hinchliffe M.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
    [Abstract] [Full Text] [Related]

  • 13. [Recent advances in hypoxic cell radiosensitizer].
    Ono K, Takahashi M, Nishidai T, Shibamoto Y, Abe M.
    Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470
    [Abstract] [Full Text] [Related]

  • 14. Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.
    Dische S.
    Radiother Oncol; 1985 Feb; 3(2):97-115. PubMed ID: 3157206
    [Abstract] [Full Text] [Related]

  • 15. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
    Tanaka M, Fukuda H, Nakajima T, Sugimoto K, Onoyama Y, Hori H, Inayama S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct 25; 48(10):1249-60. PubMed ID: 3222139
    [No Abstract] [Full Text] [Related]

  • 16. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
    Martin WM, McNally NJ, De Ronde J.
    Br J Cancer; 1981 Jun 25; 43(6):756-66. PubMed ID: 7248157
    [Abstract] [Full Text] [Related]

  • 17. Testing of new hypoxic cell sensitizers in vivo.
    Stone HB, Sinesi MS.
    Radiat Res; 1982 Jul 25; 91(1):186-98. PubMed ID: 6212963
    [No Abstract] [Full Text] [Related]

  • 18. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP, Hirst DG, Brown JM.
    Br J Cancer; 1981 Aug 25; 44(2):208-18. PubMed ID: 7272187
    [Abstract] [Full Text] [Related]

  • 19. Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: influence on repair of potentially lethal damage.
    Guichard M, Malaise EP.
    Int J Radiat Oncol Biol Phys; 1982 Aug 25; 8(3-4):465-8. PubMed ID: 6213589
    [Abstract] [Full Text] [Related]

  • 20. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW.
    Br J Cancer; 1981 Mar 25; 43(3):367-77. PubMed ID: 7225287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.